tiprankstipranks
Trending News
More News >

Harshad Angel - New Portfolio

HARSHAD SOLANKI

Harshad Angel
Individual Investor
Ranked #365,678 out of 795,507 TipRanks' Investors
Success Rate
33%
36 out of 110
profitable transactions
Average Return
-2.67%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▼ 25.57%
6-Month Return▼ 36.44%
12-Month Return▼ 43.68%
YTD Return▼ 45.24%
Total Return▼ 31.76%

Best Trade

Opened at
Closed at-
Gain▲ 754.17%

Bio

Managing my funds for maximum returns

Performance

25.98%0-25.98%
▲ 2.92%
▲ 2.10%
▲ 5.65%
Sep 2024
▲ 10.00%
▼ 0.89%
▲ 2.25%
Oct 2024
▲ 25.98%
▲ 5.96%
▲ 23.11%
Nov 2024
▲ 5.34%
▼ 2.41%
▼ 7.88%
Dec 2024
▲ 5.99%
▲ 2.69%
▼ 10.26%
Jan 2025
▼ 12.86%
▼ 1.27%
▼ 17.90%
Feb 2025
▼ 1.80%
▼ 5.57%
▼ 14.96%
Mar 2025
▼ 13.55%
▼ 6.22%
▼ 12.60%
Apr 2025
TipRanks AverageS&P 500Investor Portfolio
▲ 2.92%▲ 2.10%▲ 5.65%
▲ 10.00%▼ 0.89%▲ 2.25%
▲ 25.98%▲ 5.96%▲ 23.11%
▲ 5.34%▼ 2.41%▼ 7.88%
▲ 5.99%▲ 2.69%▼ 10.26%
▼ 12.86%▼ 1.27%▼ 17.90%
▼ 1.80%▼ 5.57%▼ 14.96%
▼ 13.55%▼ 6.22%▼ 12.60%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Plug Power
3.42%
▼ 55.29%
16
Buy
Mar 29, 2025
TScan Therapeutics
18.74%
▼ 52.06%
11
Buy
Mar 29, 2025
Agenus
11.99%
▼ 48.77%
10
Buy
Mar 29, 2025
Atara Biotherapeutics
16.71%
▼ 50.62%
13
Buy
Mar 29, 2025
Viking Therapeutics
15.67%
▼ 28.79%
4
Buy
Mar 29, 2025
Arbe Robotics
4.35%
▼ 22.96%
3
Buy
Mar 29, 2025
Praxis Precision Medicines
0%
▼ 22.95%
1
Open
Feb 28, 2025
Lumen Technologies
0%
▼ 26.23%
1
Open
Feb 20, 2025
Nvidia
11.17%
▲ 13.09%
16
Sell
Feb 05, 2025
Akebia Therapeutics
0%
▲ 20.44%
2
Sell
Feb 04, 2025
Opendoor Technologies
1.03%
▼ 22.73%
1
Open
Feb 04, 2025
BioCryst
6.87%
▲ 17.07%
10
Buy
Jan 11, 2025
Dogecoin
0%
▼ 61.86%
1
Open
Dec 13, 2024
Taysha Gene Therapies
8.78%
▼ 43.48%
9
Buy
Oct 21, 2024
Fuelcell Energy
0.01%
▲ 393.93%
9
Sell
Oct 21, 2024
Vuzix
0%
▲ 25.56%
4
Sell
Oct 21, 2024
Costco
0.49%
▲ 11.84%
3
Buy
Oct 21, 2024
Oncolytics Biotech
0.63%
▼ 50.63%
1
Open
Oct 21, 2024
Sonnet BioTherapeutics Holdings
0.16%
▼ 87.31%
5
Buy
Sep 13, 2024
Alphabet Class A
0%
▼ 3.78%
9
Sell
Sep 06, 2024